Dystrophinopathies

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This article discusses various dystrophinopathies and highlights recent developments in gene therapies, indicating evolving treatment options.

Recent gene therapies aim to directly address the genetic defects in conditions like duchenne muscular dystrophy, enhancing treatment strategies.
Elevated creatine kinase levels and progressive weakness are key indicators of dystrophinopathies, assisting in early diagnosis.
Corticosteroids remain the primary pharmacologic option to manage symptoms and delay complications during patient care.
Genetic testing plays a crucial role in diagnosing dystrophinopathies and guiding treatment plans, depending on the identified variant.

Jayaraman et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This article discusses various dystrophinopathies and highlights recent developments in gene therapies, indicating evolving treatment options.